Atlas Trials

Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia

Clinical trial NCT05832125 · UNKNOWN

Trial details

NCT number
NCT05832125
Sponsor
Versailles Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Relapsed/Refractory Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Leukemia
Start date
2021-12-14
Primary completion
2023-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.